RPG Life Sciences Ltd. News and Updates

Name: Latest research reports of RPG Life Sciences Ltd. authored by Chola Wealth Direct and published by - Trendlyne research reports.
Item: RPG Life Sciences Ltd.
Rating: 5
Author: Chola Wealth Direct

Keep track of all breaking news on RPG Life Sciences Ltd. from all sources in a single place.

Load latest

RPG Life Sciences Ltd.

31 Jul 2023

2027.40

1.04%

RPG Life Sciences hits 52-week high as Q1 profit surges 22%

Moneycontrol

RPG Life Sciences on Friday reported a 15 percent year-on-year (YoY) increase in revenue from operations for Q1FY24 at Rs 148 crore as compared to Rs 129 crore reported in Q1FY23.

RPG Life Sciences Ltd. has lost -24.18% in the last 6 Months

RPG Life Sciences Ltd.

16 Jun 2023

2027.40

1.04%

RPG Life Sciences (NOT RATED): Investor day takeaways Foundation in place; now targeting scale

Not Rated: RPG Life Sciences Ltd.

BOB Capital Markets Ltd.

FY23 a milestone year with revenue/EBITDA of Rs 500mn/100mn; Naprosyn brand crossed Rs 500mn

RPG Life Sciences Ltd. is trading below all available SMAs

RPG Life Sciences Ltd.

02 May 2023

2027.40

1.04%

to see Rapid results content

RPG Life Sciences Ltd.

29 Apr 2023

2027.40

1.04%

Multibagger pharma stock up over 230% in 3 years, Board declares 150% dividend

livemint

RPG Life Sciences, a small-cap firm, closed on Friday with a market valuation of 1,382.08 Cr.

RPG Life Sciences Ltd. has gained 39.92% in the last 1 Year

RPG Life Sciences Ltd.

01 Feb 2023

2027.40

1.04%

to see Rapid results content

RPG Life Sciences Ltd.

18 Jan 2023

2027.40

1.04%

TECHNO FUNDA - RPG LIFE SCIENCES

Buy: RPG Life Sciences Ltd.

Chola Wealth Direct

RPG Life Sciences Ltd. is trading below all available SMAs

RPG Life Sciences Ltd.

29 Nov 2022

2027.40

1.04%

Need separate ministry for pharma to counter Chinese imports: Industry CEOs

Business Standard

The government needs to set up a separate ministry for the pharma sector to encourage domestic producers and decrease Chinese imports, opined CEOs while participating in a discussion on the challenges being faced by the sector. In a CEO Roundtable at the 15th edition of CPHI & PMEC India held on Tuesday, the Chief Executive Officers (CEOs) of companies, including those from RPG Life Science and Fermenta Biotech, also discussed ways to shift the focus of the domestic industry from volume to value. The leaders also pointed out the need to reduce dependency on China by using technology. Organisation of Pharmaceutical Producers of India (OPPI) Director General Vivek Sehgal said that the industry needs to collaborate and co-work and unite for collective voice on IPR related issues. The leaders also discussed having a single industry organisation to put across the grievances of the pharma industry before the government. Speaking at the inaugural session of the 15th edition of CPHI &

RPG Life Sciences Ltd. has gained 39.92% in the last 1 Year

RPG Life Sciences Ltd.

19 Oct 2022

2027.40

1.04%

Results Earnings Call for Q2FY23 of RPG Life Sciences

Conference Call with RPG Life Sciences Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

RPG Life Sciences Ltd.

18 Oct 2022

2027.40

1.04%

to see Rapid results content

RPG Life Sciences Ltd.

20 Sep 2022

2027.40

1.04%

Hot Stocks | RPG Life Sciences, Poonawalla Fincorp, Welspun can deliver over 10% return in short term. Here's why

Moneycontrol

RPG Life Sciences has broken out from the Bullish Flag pattern on the daily chart. Stock has been forming higher tops and higher bottoms on the daily charts. Recently the stock price registered fresh all-time high at Rs 804 and current levels are very near to that level.

RPG Life Sciences Ltd. has gained 39.92% in the last 1 Year

Is RPG Life Sciences Ltd. worth buying?

79 Votes:

Buy 72.15%

Sell 17.72%

Hold 10.13%

31.85% Fall from 52W High

RPG Life Sciences Ltd. News and Updates

Keep track of all breaking news on RPG Life Sciences Ltd. from all sources in a single place.